{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:06:29Z","timestamp":1789239989613,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.7759\/cureus.23784","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:34:58Z","timestamp":1648996498000},"source":"Crossref","is-referenced-by-count":9,"title":["Risk of Stroke With Mitral Stenosis: The Underlying Mechanism, Treatment, and Prevention"],"prefix":"10.7759","author":[{"given":"Hamza","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Madhurima","family":"Puttagunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajkumar B","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Vanessa","family":"Flores Monar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4870.1051","article-title":"An appreciation of mitral stenosis. I. Clinical features","volume":"1","author":"Wood P","year":"1954","unstructured":"Wood P. An appreciation of mitral stenosis. I. Clinical features. Br Med J. 1954, 1:1051-63; contd. 10.1136\/bmj.1.4870.1051","journal-title":"Br Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208063270602","article-title":"Mitral annular calcification and the risk of stroke in an elderly cohort","volume":"327","author":"Benjamin EJ","year":"1992","unstructured":"Benjamin EJ, Plehn JF, D'Agostino RB, et al.. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med. 1992, 327:374-9. 10.1056\/NEJM199208063270602","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf PA","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978, 28:973-7. 10.1212\/wnl.28.10.973","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050140","article-title":"Mitral annulus calcification is not an independent risk factor for stroke: a cohort study of 657 patients","volume":"244","author":"Boon A","year":"1997","unstructured":"Boon A, Lodder J, Cheriex E, Kessels F. Mitral annulus calcification is not an independent risk factor for stroke: a cohort study of 657 patients. J Neurol. 1997, 244:535-41. 10.1007\/s004150050140","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60994-6","article-title":"Mitral stenosis","volume":"374","author":"Chandrashekhar Y","year":"2009","unstructured":"Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet. 2009, 374:1271-83. 10.1016\/S0140-6736(09)60994-6","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050347","article-title":"Overestimation of stroke risk in rheumatic mitral stenosis and the implications for oral anticoagulation","volume":"142","author":"Karthikeyan G","year":"2020","unstructured":"Karthikeyan G, Connolly SJ, Yusuf S. Overestimation of stroke risk in rheumatic mitral stenosis and the implications for oral anticoagulation. Circulation. 2020, 142:1697-9. 10.1161\/CIRCULATIONAHA.120.050347","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(60)80009-6","article-title":"The management of rheumatic heart disease in relation to systemic arterial embolism","volume":"3","author":"Askey JM","year":"1960","unstructured":"Askey JM, Bernstein S. The management of rheumatic heart disease in relation to systemic arterial embolism. Prog Cardiovasc Dis. 1960, 3:220-32. 10.1016\/S0033-0620(60)80009-6","journal-title":"Prog Cardiovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy","volume":"35","author":"Hart RG","year":"2000","unstructured":"Hart RG, Pearce LA, Rothbart RM. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol. 2000, 35:183-7. 10.1016\/s0735-1097(99)00489-1","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang RM","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015, 28:1-39.e14. 10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227753","article-title":"Morphological and functional characteristics of mitral annular calcification and their relationship to stroke","volume":"15","author":"Kim D","year":"2020","unstructured":"Kim D, Shim CY, Hong GR, Jeong H, Ha JW. Morphological and functional characteristics of mitral annular calcification and their relationship to stroke. PLoS One. 2020, 15:e0227753. 10.1371\/journal.pone.0227753","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e32834f2336","article-title":"Stroke prevention in atrial fibrillation","volume":"13","author":"Mohammed I","year":"2012","unstructured":"Mohammed I, Mohmand-Borkowski A, Burke JF, Kowey PR. Stroke prevention in atrial fibrillation. J Cardiovasc Med (Hagerstown). 2012, 13:73-85. 10.2459\/JCM.0b013e32834f2336","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref12","article-title":"Long-term follow up after successful percutaneous balloon mitral valvuloplasty","volume":"26","author":"Rodrigues I","year":"2017","unstructured":"Rodrigues I, Branco L, Patr\u00edcio L, et al.. Long-term follow up after successful percutaneous balloon mitral valvuloplasty. J Heart Valve Dis. 2017, 26:659-66.","journal-title":"J Heart Valve Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26204","article-title":"Advanced cardiac MRI techniques for evaluation of left-sided valvular heart disease","volume":"48","author":"Blanken CP","year":"2018","unstructured":"Blanken CP, Farag ES, Boekholdt SM, et al.. Advanced cardiac MRI techniques for evaluation of left-sided valvular heart disease. J Magn Reson Imaging. 2018, 48:318-29. 10.1002\/jmri.26204","journal-title":"J Magn Reson Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2017.12.007","article-title":"Transcatheter mitral valve replacement in mitral annulus calcification - \"the art of computer simulation\"","volume":"12","author":"Kar\u00e1dy J","year":"2018","unstructured":"Kar\u00e1dy J, Ntalas I, Prendergast B, Blauth C, Niederer S, Maurovich-Horvat P, Rajani R. Transcatheter mitral valve replacement in mitral annulus calcification - \"the art of computer simulation\". J Cardiovasc Comput Tomogr. 2018, 12:153-7. 10.1016\/j.jcct.2017.12.007","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-11-199806010-00001","article-title":"Predictors of systemic embolism in patients with mitral stenosis. A prospective study","volume":"128","author":"Chiang CW","year":"1998","unstructured":"Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH. Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med. 1998, 128:885-9. 10.7326\/0003-4819-128-11-199806010-00001","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.844779","article-title":"Left atrial appendage occlusion does not eliminate the need for warfarin","volume":"120","author":"Whitlock RP","year":"2009","unstructured":"Whitlock RP, Healey JS, Connolly SJ. Left atrial appendage occlusion does not eliminate the need for warfarin. Circulation. 2009, 120:1927-32; discussion 1932. 10.1161\/CIRCULATIONAHA.108.844779","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.019","article-title":"Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation","volume":"97","author":"Douglas YL","year":"2006","unstructured":"Douglas YL, Jongbloed MR, Gittenberger-de Groot AC, et al.. Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation. Am J Cardiol. 2006, 97:662-70. 10.1016\/j.amjcard.2005.11.019","journal-title":"Am J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study","volume":"60","author":"Di Biase L","year":"2012","unstructured":"Di Biase L, Santangeli P, Anselmino M, et al.. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012, 60:531-8. 10.1016\/j.jacc.2012.04.032","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.82.5.547","article-title":"Left atrial appendage: structure, function, and role in thromboembolism","volume":"82","author":"Al-Saady NM","year":"1999","unstructured":"Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999, 82:547-54. 10.1136\/hrt.82.5.547","journal-title":"Heart"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.73.6.527","article-title":"Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment","volume":"73","author":"Lip GY","year":"1995","unstructured":"Lip GY, Lowe GD, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J. 1995, 73:527-33. 10.1136\/hrt.73.6.527","journal-title":"Br Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.110284","article-title":"Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study","volume":"140","author":"Goldsmith I","year":"2000","unstructured":"Goldsmith I, Kumar P, Carter P, Blann AD, Patel RL, Lip GY. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. Am Heart J. 2000, 140:777-84. 10.1067\/mhj.2000.110284","journal-title":"Am Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear JL","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996, 61:755-9. 10.1016\/0003-4975(95)00887-X","journal-title":"Ann Thorac Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90652-1","article-title":"Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation","volume":"23","author":"Manning WJ","year":"1994","unstructured":"Manning WJ, Silverman DI, Katz SE, et al.. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994, 23:1535-40. 10.1016\/0735-1097(94)90652-1","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.854.731","article-title":"Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy","volume":"72","author":"Lip GY","year":"1996","unstructured":"Lip GY. Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy. Postgrad Med J. 1996, 72:731-8. 10.1136\/pgmj.72.854.731","journal-title":"Postgrad Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000065431.76788.D9","article-title":"Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?","volume":"34","author":"Mar\u00edn F","year":"2003","unstructured":"Mar\u00edn F, Rold\u00e1n V, Climent V, Garcia A, Marco P, Lip GY. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?. Stroke. 2003, 34:1181-6. 10.1161\/01.STR.0000065431.76788.D9","journal-title":"Stroke"},{"key":"ref26","article-title":"Calcification of the mitral annulus fibrosus with systemic embolization. a clinicopathologic study of 16 cases","volume":"111","author":"Lin CS","year":"1987","unstructured":"Lin CS, Schwartz IS, Chapman I. Calcification of the mitral annulus fibrosus with systemic embolization. a clinicopathologic study of 16 cases. Arch Pathol Lab Med. 1987, 111:411-4.","journal-title":"Arch Pathol Lab Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.035","article-title":"Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation","volume":"49","author":"Sick PB","year":"2007","unstructured":"Sick PB, Schuler G, Hauptmann KE, et al.. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007, 49:1490-5. 10.1016\/j.jacc.2007.02.035","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hps082","article-title":"Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study","volume":"26","author":"De Marco M","year":"2013","unstructured":"De Marco M, Gerdts E, Casalnuovo G, et al.. Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study. Am J Hypertens. 2013, 26:567-73. 10.1093\/ajh\/hps082","journal-title":"Am J Hypertens"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613584","article-title":"Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment","volume":"89","author":"Pengo V","year":"2003","unstructured":"Pengo V, Barbero F, Biasiolo A, Pegoraro C, Noventa F, Iliceto S. Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment. Thromb Haemost. 2003, 89:760-4. 10.1055\/s-0037-1613584","journal-title":"Thromb Haemost"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi667","article-title":"Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial","volume":"27","author":"P\u00e9rez-G\u00f3mez F","year":"2006","unstructured":"P\u00e9rez-G\u00f3mez F, Salvador A, Zumalde J, et al.. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial. Eur Heart J. 2006, 27:960-7. 10.1093\/eurheartj\/ehi667","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death. The Framingham Heart Study","volume":"98","author":"Benjamin EJ","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation. 1998, 98:946-52. 10.1161\/01.cir.98.10.946","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-318756","article-title":"Stroke risk in rheumatic heart disease","volume":"107","author":"Karthikeyan G","year":"2021","unstructured":"Karthikeyan G. Stroke risk in rheumatic heart disease. Heart. 2021, 107:694-6. 10.1136\/heartjnl-2020-318756","journal-title":"Heart"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.12.016","article-title":"Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: results of SMART-India, a population-based screening study","volume":"280","author":"Soni A","year":"2019","unstructured":"Soni A, Karna S, Fahey N, et al.. Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: results of SMART-India, a population-based screening study. Int J Cardiol. 2019, 280:84-8. 10.1016\/j.ijcard.2018.12.016","journal-title":"Int J Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study","volume":"376","author":"O'Donnell MJ","year":"2010","unstructured":"O'Donnell MJ, Xavier D, Liu L, et al.. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study. Lancet. 2010, 376:112-23. 10.1016\/S0140-6736(10)60834-3","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.026","article-title":"Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan","volume":"66","author":"Chao TF","year":"2015","unstructured":"Chao TF, Wang KL, Liu CJ, et al.. Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan. J Am Coll Cardiol. 2015, 66:1339-47. 10.1016\/j.jacc.2015.07.026","journal-title":"J Am Coll Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip GY","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010, 137:263-72. 10.1378\/chest.09-1584","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart RG","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146:857-67. 10.7326\/0003-4819-146-12-200706190-00007","journal-title":"Ann Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/752808","article-title":"Left atrial appendage closure in atrial fibrillation: a world without anticoagulation?","volume":"2011","author":"Contractor T","year":"2011","unstructured":"Contractor T, Khasnis A. Left atrial appendage closure in atrial fibrillation: a world without anticoagulation?. Cardiol Res Pract. 2011, 2011:752808. 10.4061\/2011\/752808","journal-title":"Cardiol Res Pract"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl129","article-title":"A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash A","year":"2007","unstructured":"Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing. 2007, 36:151-6. 10.1093\/ageing\/afl129","journal-title":"Age Ageing"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005835","article-title":"Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis","volume":"6","author":"Pan KL","year":"2017","unstructured":"Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis. J Am Heart Assoc. 2017, 6:e005835. 10.1161\/JAHA.117.005835","journal-title":"J Am Heart Assoc"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.12.047","article-title":"Outcomes of direct oral anticoagulants in patients with mitral stenosis","volume":"73","author":"Kim JY","year":"2019","unstructured":"Kim JY, Kim SH, Myong JP, et al.. Outcomes of direct oral anticoagulants in patients with mitral stenosis. J Am Coll Cardiol. 2019, 73:1123-31. 10.1016\/j.jacc.2018.12.047","journal-title":"J Am Coll Cardiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afv071","article-title":"Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice","volume":"44","author":"Wolff A","year":"2015","unstructured":"Wolff A, Shantsila E, Lip GY, Lane DA. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. Age Ageing. 2015, 44:874-8. 10.1093\/ageing\/afv071","journal-title":"Age Ageing"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm AJ","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, et al.. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012, 33:2719-47. 10.1093\/eurheartj\/ehs253","journal-title":"Eur Heart J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2147\/MDER.S70672","article-title":"Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials","volume":"8","author":"Proietti R","year":"2015","unstructured":"Proietti R, Joza J, Arensi A, et al.. Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials. Med Devices (Auckl). 2015, 8:103-14. 10.2147\/MDER.S70672","journal-title":"Med Devices (Auckl)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom JW","year":"2011","unstructured":"Eikelboom JW, Wallentin L, Connolly SJ, et al.. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011, 123:2363-72. 10.1161\/CIRCULATIONAHA.110.004747","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano RP","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, et al.. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013, 369:2093-104. 10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-011-0559-8","article-title":"New oral anticoagulants","volume":"31","author":"Galanis T","year":"2011","unstructured":"Galanis T, Thomson L, Palladino M, Merli GJ. New oral anticoagulants. J Thromb Thrombolysis. 2011, 31:310-20. 10.1007\/s11239-011-0559-8","journal-title":"J Thromb Thrombolysis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-013-0055-y","article-title":"Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects","volume":"14","author":"Wang X","year":"2014","unstructured":"Wang X, Mondal S, Wang J, Tirucherai G, Zhang D, Boyd RA, Frost C. Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects. Am J Cardiovasc Drugs. 2014, 14:147-54. 10.1007\/s40256-013-0055-y","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack CV Jr","year":"2015","unstructured":"Pollack CV Jr, Reilly PA, Eikelboom J, et al.. Idarucizumab for dabigatran reversal. N Engl J Med. 2015, 373:511-20. 10.1056\/NEJMoa1502000","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13207","article-title":"Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation","volume":"24","author":"Tan J","year":"2019","unstructured":"Tan J, Bae S, Segal JB, Zhu J, Alexander GC, Segev DL, McAdams-DeMarco M. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation. Nephrology (Carlton). 2019, 24:234-44. 10.1111\/nep.13207","journal-title":"Nephrology (Carlton)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant J","year":"2007","unstructured":"Mant J, Hobbs FD, Fletcher K, et al.. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007, 370:493-503. 10.1016\/S0140-6736(07)61233-1","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25489","article-title":"Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation","volume":"85","author":"Seiffge DJ","year":"2019","unstructured":"Seiffge DJ, Paciaroni M, Wilson D, et al.. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol. 2019, 85:823-34. 10.1002\/ana.25489","journal-title":"Ann Neurol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003206","article-title":"Comparative effectiveness of interventions for stroke prevention in atrial fibrillation: a network meta-analysis","volume":"5","author":"Tereshchenko LG","year":"2016","unstructured":"Tereshchenko LG, Henrikson CA, Cigarroa J, Steinberg JS. Comparative effectiveness of interventions for stroke prevention in atrial fibrillation: a network meta-analysis. J Am Heart Assoc. 2016, 5:e003206. 10.1161\/JAHA.116.003206","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86048-risk-of-stroke-with-mitral-stenosis-the-underlying-mechanism-treatment-and-prevention","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:56Z","timestamp":1707507836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86048-risk-of-stroke-with-mitral-stenosis-the-underlying-mechanism-treatment-and-prevention"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.23784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,3]]}}}